What America Needs From a New FDA Commissioner

More than any other in recent memory, this administration has been willing to be bold in defense of American interests. It must do so for US biotech as well. Our US biotech ecosystem is in crisis: to be blunt, China's industrial policy combined with a sclerotic FDA over the previous decade is stealing and eroding away the industry. This is happening at a time when AI breakthroughs should be accelerating faster and cheaper cures.